Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 3/20 | 0.30 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.30 |
| ▸ | MGLL | Q99685 | 2/20 | 0.30 |
| ▸ | FAAH | O00519 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1095049 | 0.98 | PTGS1 (0.33) | PTGS1PTGS2MGLLFAAH | |
| SCHEMBL1094161 | 0.98 | PTGS1 (0.33) | PTGS1PTGS2MGLLFAAH | |
| SCHEMBL1095919 | 0.95 | — | — | |
| SCHEMBL1094897 | 0.88 | — | — | |
| SCHEMBL1095387 | 0.82 | — | — | |
| SCHEMBL1950829 | 0.79 | PTGS1 (0.33) | PTGS1PTGS2MGLLFAAH | |
| SCHEMBL15170315 | 0.75 | CA1 (0.31) | — | |
| SCHEMBL15170577 | 0.75 | CYP1A2 (0.33) | — | |
| SCHEMBL3340040 | 0.75 | PTGS1 (0.33) | PTGS1PTGS2MGLLFAAH | |
| SCHEMBL3339691 | 0.75 | PTGS1 (0.33) | PTGS1PTGS2MGLLFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3239179-B1 | REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTERS PRODUCED IN A CARBOXYLATED IONIC LIQUID PROCESS AND PRODUCTS PRODUCED THEREFROM | EASTMAN CHEM CO (US) | 2023-02-22 | — | — | EP | disclosed |
| CN-103923352-B | Regioselectively substituted cellulose esters prepared by carboxylated ionic liquid processes and products prepared therefrom | 伊士曼化工公司 | 2020-10-16 | — | — | CN | disclosed |
| EP-2313438-B1 | REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTERS PRODUCED IN A HALOGENATED IONIC LIQUID PROCESS AND PRODUCTS PRODUCED THEREFROM | EASTMAN CHEM CO (US) | 2019-09-18 | — | — | EP | disclosed |
| US-10174129-B2 | Regioselectively substituted cellulose esters produced in a carboxylated ionic liquid process and products produced therefrom | EASTMAN CHEMICAL COMPANY (US) | 2019-01-08 | — | — | US | disclosed |
| US-9834516-B2 | Regioselectively substituted cellulose esters produced in a carboxylated ionic liquid process and products produced therefrom | EASTMAN CHEMICAL COMPANY (US) | 2017-12-05 | — | — | US | disclosed |
| EP-3239179-A1 | REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTERS PRODUCED IN A CARBOXYLATED IONIC LIQUID PROCESS AND PRODUCTS PRODUCED THEREFROM | Eastman Chemical Company (US) | 2017-11-01 | — | — | EP | disclosed |
| US-9777074-B2 | Regioselectively substituted cellulose esters produced in a halogenated ionic liquid process and products produced therefrom | EASTMAN CHEMICAL COMPANY (US) | 2017-10-03 | — | — | US | disclosed |
| US-20170204201-A1 | REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTERS PRODUCED IN A CARBOXYLATED IONIC LIQUID PROCESS AND PRODUCTS PRODUCED THEREFROM | EASTMAN CHEMICAL COMPANY (US) | 2017-07-20 | — | — | US | disclosed |
| US-20160108137-A1 | REGIOSELECTIVELY SUBSTITUTED CELLULOSE ESTERS PRODUCED IN A HALOGENATED IONIC LIQUID PROCESS AND PRODUCTS PRODUCED THEREFROM | EASTMAN CHEMICAL COMPANY (US) | 2016-04-21 | — | — | US | disclosed |
| US-9175096-B2 | Regioselectively substituted cellulose esters produced in a halogenated ionic liquid process and products produced therefrom | EASTMAN CHEMICAL COMPANY (US) | 2015-11-03 | — | — | US | disclosed |
| WO-2009102305-A1 | TREATMENT OF CELLULOSE ESTERS | EASTMAN CHEMICAL COMPANY (US) | 2009-08-20 | — | — | WO | disclosed |
| US-20090203899-A1 | TREATMENT OF CELLULOSE ESTERS | EASTMAN CHEMICAL COMPANY (US) | 2009-08-13 | — | — | US | disclosed |
| US-20090203900-A1 | PRODUCTION OF CELLULOSE ESTERS IN THE PRESENCE OF A COSOLVENT | EASTMAN CHEMICAL COMAPANY (US) | 2009-08-13 | — | — | US | disclosed |
| US-20090203898-A1 | CELLULOSE ESTERS AND THEIR PRODUCTION IN HALOGENATED IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2009-08-13 | — | — | US | disclosed |
| WO-2008100566-A1 | CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-21 | — | — | WO | disclosed |
| WO-2008100569-A1 | REFORMATION OF IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-21 | — | — | WO | disclosed |
| WO-2008100577-A1 | PRODUCTION OF IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-21 | — | — | WO | disclosed |
| US-20080194834-A1 | PRODUCTION OF IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-14 | — | — | US | disclosed |
| US-20080194808-A1 | CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-14 | — | — | US | disclosed |
| US-20080194807-A1 | REFORMATION OF IONIC LIQUIDS | EASTMAN CHEMICAL COMPANY (US) | 2008-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080194834-A1 | PRODUCTION OF IONIC LIQUIDS | GLUL, ICMT, ALAD | PTGS1 2654/4885PTGS2 2019/4885MGLL 396/4885 |
| US-20080194808-A1 | CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS | CEL, ACMSD, ACOT7 | PTGS1 4260/4885PTGS2 4208/4885MGLL 84/4885 |
| US-10174129-B2 | Regioselectively substituted cellulose esters produced in a carboxylated ionic liquid process and products produced therefrom | MGAM, CEL, MGAM2 | PTGS1 4499/4885PTGS2 3621/4885MGLL 109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.